At a glance
- Originator Kao Corporation; Nonindustrial source
- Class Cytostatic antibiotics; Macrolides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 31 May 2001 Discontinued-Preclinical for Cancer in Japan (Unknown route)
- 08 Feb 2001 Profile reviewed but no significant changes made
- 18 Sep 1998 Profile reviewed